ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
5 hedge funds and large institutions have $18.7K invested in Anthera Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 24 closing their positions.
Holders
5
Holders Change
-23
Holders Change %
-82.14%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WS
1
Wedbush Securities
Los Angeles,
California
|
$17K |
| 2 |
MAM
2
Meeder Asset Management
Dublin,
Ohio
|
$714 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| – | – | -6 | Closed |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -3 | Closed |
|
28
Alyeska Investment Group
Chicago,
Illinois
| – | – | – | – |
|
|
FIA
29
FNY Investment Advisers
New York
| – | – | – | – |
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
|
LTFS
31
Ladenburg Thalmann Financial Services
Miami,
Florida
| $0 | 1,500 | – | – |
|
|
SMFS
32
Squar Milner Financial Services
Irvine,
California
| $0 | 50 | +50 | New |
|